Cite
Development and validation of reassigned CEA, CYFRA21-1 and NSE-based models for lung cancer diagnosis and prognosis prediction
MLA
Jingmin Yuan, et al. “Development and Validation of Reassigned CEA, CYFRA21-1 and NSE-Based Models for Lung Cancer Diagnosis and Prognosis Prediction.” BMC Cancer, vol. 22, no. 1, June 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7fc19c6897fb34bb3cc7a3430f6d8228&authtype=sso&custid=ns315887.
APA
Jingmin Yuan, Yan Sun, Ke Wang, Zhiyi Wang, Duo Li, Meng Fan, Xiang Bu, Jun Chen, Zhiquan Wu, Hui Geng, Jiamei Wu, Ying Xu, Mingwei Chen, & Hui Ren. (2021). Development and validation of reassigned CEA, CYFRA21-1 and NSE-based models for lung cancer diagnosis and prognosis prediction. BMC Cancer, 22(1).
Chicago
Jingmin Yuan, Yan Sun, Ke Wang, Zhiyi Wang, Duo Li, Meng Fan, Xiang Bu, et al. 2021. “Development and Validation of Reassigned CEA, CYFRA21-1 and NSE-Based Models for Lung Cancer Diagnosis and Prognosis Prediction.” BMC Cancer 22 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7fc19c6897fb34bb3cc7a3430f6d8228&authtype=sso&custid=ns315887.